Ingen internetforbindelse — viser den gemte version af siden.

Sorrento Therape

USUSD
← Til screeneren

Sorrento Therape (US:SRNE) — Biotechnology. Antal børser, hvor selskabets aktier handles: 1. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

Om virksomheden

Websted
sorrentotherapeutics.com
Sektor
Healthcare · Biotechnology
Hovedkontor
San Diego, United States
Ledelse
Henry H. Ji
Ansatte
949
Udestående aktier
551.28 mio.
Free float
539.11 mio.
Markedsværdi
165 384 USD
Insidere
0%
Institutionelle investorer
0.04%
Beskrivelse

Sorrento Therapeutics, Inc., a clinical and commercial stage biopharmaceutical company, provides therapeutic solutions in the United States and internationally. It offers chimeric antigen receptor T-cell therapy, dimeric antigen receptor T-cell therapy, and antibody-drug conjugates, as well as Seprehvec, SOFUSA, RTX, and SEMDEXA. The company also develops antiviral therapies and vaccines, including Abivertinib, COVI-MSC, COVI-AMG, COVIDROPS, and COVI SHIELD; and diagnostic test solutions, such as COVISTIX, COVITRACK, and Virex. Its products are used for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases treatment. The company was founded in 2006 and is based in San Diego, California. On February 13, 2023, Sorrento Therapeutics, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas. The plan was later approved as Chapter 11 liquidation on November 30, 2023.

annonce

Børser og tickere

BørsTickerValutaPrisType
US USA StocksSRNEUSD0.0003 +0.00%almindelige aktier

Pris

US:SRNE · USD
Hold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs

Største ejere

EjerAndelAktierRapportdato
Vsm Wealth Advisory, LLC0.02%110 1002026-06-30
Huntington National Bank0%5 0012026-06-30
Guggenheim Active Alloca…0%3 4812026-08-31
Oakworth Capital, Inc.0%3502026-09-30
Financial Gravity Compan…0%182026-06-30